NCT02997111 is a NA clinical trial of PFA-100 in Platelet Function, sponsored by St. Louis University.

Who is sponsoring NCT02997111?

NCT02997111 is sponsored by St. Louis University.

What drugs are being tested in NCT02997111?

Interventions in NCT02997111: PFA-100.

What condition does NCT02997111 study?

NCT02997111 studies Platelet Function, Thrombosis.

Is NCT02997111 still recruiting?

NCT02997111 is currently completed. Last updated 22 June 2017.

Last reviewed 2017-06-22 · How we verify

NCT02997111

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

PFA-100 Responsive to Effect of Energy Drinks on Platelet Function

Completed NA Last updated 22 June 2017

What this trial tests

NA trial testing PFA-100 in Platelet Function in 13 participants. Completed in 20 June 2017.

Timeline

14 February 2017

Primary endpoint
9 June 2017

20 June 2017

Quick facts

Lead sponsor	St. Louis University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	other
Enrollment	13
Start date	14 February 2017
Primary completion	9 June 2017
Estimated completion	20 June 2017
Sites	1 location across United States

Drugs / interventions tested

PFA-100

Conditions studied

Platelet Function — all drugs for Platelet Function →
Thrombosis — all drugs for Thrombosis →

Sponsor

St. Louis University

Who can join

Adults 18 to 35, any sex, with Platelet Function or Thrombosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study evaluates the responsiveness of the Platelet Function Analyzer (PFA-100) to the effect of energy drinks on platelet function. Participants' will have blood drawn prior to and 60 minutes after ingesting 250ml of a commercially available sugar-free energy drink.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other St. Louis University trials

Trials by the same sponsor.

NCT07024940 — Short-term Effects of Caffeine and a Multi-ingredient Pre-workout on Exercise Performance · NA · recruiting
NCT06859528 — Step Up to PD: A Community-based Walking Program for People With Parkinson's Disease · NA · recruiting
NCT04158037 — Don't Go There: A Geospatial mHealth App for Gambling Disorder · NA · withdrawn
NCT05406310 — Clinical Outcomes of Persistent Atrial Fibrillation Ablation Using Ablation Index-guided Radiofrequency Catheter Ablatio · withdrawn
NCT05854836 — Preconception Intervention for Incarcerated Women With Substance Use · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02997111 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by St. Louis University
Last refreshed: 22 June 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02997111.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing